Weighted Average Number of Shares Outstanding, Basic of Anixa Biosciences Inc from 31 Jan 2014 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Anixa Biosciences Inc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Jan 2014 to 31 Jan 2026.
  • Anixa Biosciences Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Jan 2026 was 33,240,000, a 3.2% increase year-over-year.
  • Anixa Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 32,454, a 1.7% increase from 2024.
  • Anixa Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 31,898, a 3% increase from 2023.
  • Anixa Biosciences Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 30,980, a 2% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Anixa Biosciences Inc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 33,240,000 +1,043,000 +3.2% 01 Nov 2025 31 Jan 2026 10-Q 09 Mar 2026 2026 Q1
Q3 2025 32,454 +556 +1.7% 01 Aug 2025 31 Oct 2025 10-K 12 Jan 2026 2025 FY
Q2 2025 32,476,000 +422,000 +1.3% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025 2025 Q3
Q1 2025 32,202,000 +288,000 +0.9% 01 Feb 2025 30 Apr 2025 10-Q 28 May 2025 2025 Q2
Q4 2024 32,197,000 +751,000 +2.4% 01 Nov 2024 31 Jan 2025 10-Q 09 Mar 2026 2026 Q1
Q3 2024 31,898 +918 +3% 01 Aug 2024 31 Oct 2024 10-K 12 Jan 2026 2025 FY
Q2 2024 32,054,000 +32,023,026 +103387% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025 2025 Q3
Q1 2024 31,914,000 +31,883,070 +103081% 01 Feb 2024 30 Apr 2024 10-Q 28 May 2025 2025 Q2
Q4 2023 31,446,000 +31,415,079 +101598% 01 Nov 2023 31 Jan 2024 10-Q 11 Mar 2025 2025 Q1
Q3 2023 30,980 01 Aug 2023 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q2 2023 30,974 +523 +1.7% 01 May 2023 31 Jul 2023 10-Q 06 Sep 2024 2024 Q3
Q1 2023 30,930 01 Feb 2023 30 Apr 2023 10-Q 04 Jun 2024 2024 Q2
Q4 2022 30,921 01 Nov 2022 31 Jan 2023 10-Q 12 Mar 2024 2024 Q1
Q2 2022 30,451 01 May 2022 31 Jul 2022 10-Q 06 Sep 2023 2023 Q3
Q1 2018 16,713,091 +6,978,920 +72% 01 Feb 2018 30 Apr 2018 10-Q 11 Jun 2018 2018 Q2
Q1 2017 9,734,171 +998,147 +11% 01 Feb 2017 30 Apr 2017 10-Q 11 Jun 2018 2018 Q2
Q1 2016 8,736,024 01 Feb 2016 30 Apr 2016 10-Q 26 May 2017 2017 Q2
Q4 2015 8,727,035 -61,340 -0.7% 01 Nov 2015 31 Jan 2016 10-Q 19 Feb 2016 2016 Q1
Q2 2015 8,762,540 -167,530 -1.9% 01 May 2015 31 Jul 2015 10-Q 18 Aug 2015 2015 Q3
Q4 2014 8,788,375 -201,443,852 -96% 01 Nov 2014 31 Jan 2015 10-Q 19 Feb 2016 2016 Q1
Q2 2014 8,930,070 01 May 2014 31 Jul 2014 10-Q 18 Aug 2015 2015 Q3
Q4 2013 210,232,227 01 Nov 2013 31 Jan 2014 10-Q 09 Mar 2015 2015 Q1

Anixa Biosciences Inc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 32,454 +556 +1.7% 01 Nov 2024 31 Oct 2025 10-K 12 Jan 2026 2025 FY
2024 31,898 +918 +3% 01 Nov 2023 31 Oct 2024 10-K 12 Jan 2026 2025 FY
2023 30,980 +606 +2% 01 Nov 2022 31 Oct 2023 10-K 10 Jan 2025 2024 FY
2022 30,374 01 Nov 2021 31 Oct 2022 10-K 16 Jan 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.